Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in Southern Nigeria.

Ogheneuzuazo OnwahEsther NwanjaUduak AkpanOtoyo ToyoChiagozie NwangenehBabatunde OyawolaAugustine IdemudiaKolawole OlatunbosunOnyeka IgboelinaDolapo OgundehinEzekiel JamesOkezie OnyedinachiAdeoye AdegboyeAndy Eyo

Published in: Therapeutic advances in infectious disease (2024)

PLLV was uncommon among individuals receiving dolutegravir-based ART and was associated with longer ART duration, prior viral suppression, and non-receipt of tuberculosis preventive therapy. This strengthens recommendations for continuous adherence support and comprehensive health services with ART, to prevent treatment failure.

Keyphrases

antiretroviral therapy
hiv infected
hiv aids
hiv infected patients
hiv positive
human immunodeficiency virus
mycobacterium tuberculosis
sars cov
risk factors
emergency department
clinical practice
metabolic syndrome
stem cells
pulmonary tuberculosis
weight loss
adverse drug
adipose tissue